- GlobeNewswire•4 days agoOculus Innovative Sciences Receives U.S. FDA Approval for New Post-Dermal-Procedures Product for Removal of Foreign Material Including Microorganisms
PETALUMA, Calif., Aug. 24, 2016-- Oculus Innovative Sciences, Inc., a specialty pharmaceutical company that develops and markets solutions for the treatment of dermatological conditions and advanced tissue ...
- Marketwired•11 days agoSECFilings.com: Oculus Innovative Sciences (OCLS) Tackling Eczema From the Inside Out and Outside In
SECFilings.com, a leading financial news and information portal offering free real time public company filing alerts, announces an in-depth examination of Oculus Innovative Sciences' unique and effective ...
Oculus Innovative Sciences, Inc. (OCLS)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||2.47 x 2000|
|Ask||7.40 x 1000|
|Day's Range||4.14 - 4.45|
|52wk Range||3.57 - 7.20|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-1.48|
|Avg Vol (3m)||52,936|
|Dividend & Yield||N/A (N/A)|